Drug intelligence / Profile preview

viniferin

Development stage
Unknown
Lead developer
Elysium Health
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Viniferin is a naturally occurring polyphenol and a dimer of resveratrol found in grapevines (*Vitis vinifera*), red wine, and other plant sources. It exists in several isomeric forms, most notably epsilon-viniferin (ε-viniferin) and alpha-viniferin (α-viniferin). Viniferin acts as a potent activator of sirtuin 3 (SIRT3), a mitochondrial NAD+-dependent deacetylase that regulates mitochondrial function, reduces oxidative stress, and maintains metabolic homeostasis. Preclinical studies have demonstrated that viniferin ameliorates diabetes-induced tubular injury, protects against mutant huntingtin-induced neurotoxicity in Huntington's disease models, and reduces inflammation in acute lung injury. Additionally, clinical studies have evaluated topical alpha-viniferin for *Staphylococcus aureus* nasal decolonization and skin hyperpigmentation. Viniferin is commercially available as a dietary supplement ingredient, notably as part of Elysium Health's 'Signal' mitochondrial support supplement.

Other names
alpha-viniferinepsilon-viniferinresveratrol dimertrans-epsilon-viniferintrans-ε-viniferinα-viniferinε-viniferin
02

Targets

SIRT3 (NAD-dependent protein deacetylase sirtuin-3)

Beyond the preview

Go deeper on viniferin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on viniferin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call